The DRIPBaR GREENWOOD VILLAGE
Semaglutide: Weight Loss Injections
Supresses Appetite
and Food Cravings
Semaglutide imitates GLP-1 in the body. This means that Semaglutide provides the same effect as this natural substance (GLP-1) in our bodies.
30 kg/m2 OR < (obesity)
27 kg/m2 OR < (overweight) in the presence of at least one weight-related comorbid condition
If BMI is outside range, a consult with Medical Director is required.
Personal or family history of Medullary Thyroid Carcinoma (MTC)
Personal or family history of Multiple Endocrine Neoplasia, type 2 (MEN 2)
Prior allergic reaction to Semaglutide or to any of its ingredients* (serious allergic reactions, including anaphylaxis and angioedema, have been reported with Semaglutide)
Diabetic retinopathy (diabetic eye disease)
Pregnant or trying to get pregnant (the estimated background risk of major birth defects is ~3% and the estimated background risk of miscarriage is ~18% – these percentages are increased with use of Semaglutide during pregnancy)
Breast-feeding (Semaglutide is present in breast milk)
Less than 18 years old
Depression with a history of suicidal thoughts
Supresses Appetite and Food Cravings
Your body naturally produces several substances that affect your appetite. One of these is called glucagon-like peptide-1 (GLP-1). The body produces GLP-1 naturally when you eat. GLP-1 stops you from feeling hungry and makes you feel full or satisfied.
Semaglutide imitates GLP-1 in the body. This means that Semaglutide provides the same effect as this natural substance (GLP-1) in our bodies.
30 kg/m2 or greater (obesity)
27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
If BMI is outside range, a consult with Medical Director is required.
Personal or family history of Medullary Thyroid Carcinoma (MTC)
Personal or family history of Multiple Endocrine Neoplasia, type 2 (MEN 2)
Prior allergic reaction to Semaglutide or to any of its ingredients* (serious allergic reactions, including anaphylaxis and angioedema, have been reported with Semaglutide)
Diabetic retinopathy (diabetic eye disease)
Pregnant or trying to get pregnant (the estimated background risk of major birth defects is ~3% and the estimated background risk of miscarriage is ~18% – these percentages are increased with use of Semaglutide during pregnancy)
Breast-feeding (Semaglutide is present in breast milk)
Less than 18 years old
Depression with a history of suicidal thoughts
Basic Metabolic Profile
Lipid Panel
Hemoglobin A1C
Insulin
Basic Metabolic Profile
Lipid Panel
Hemoglobin A1C
Insulin